Study #2024-1288
Phase 2 study of molecular and clinical risk-directed therapy for infants and young children with newly diagnosed medulloblastoma
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Study phase:
Physician name:
Susan McGovern
Department:
Radiation Oncology
For general questions about clinical trials:
1-844-902-2329
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.